Cargando…

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Objective: The stratification of neuroblastoma (NBL) prognosis remains difficult. RNA-based signatures might be able to predict prognosis, but independent cross-platform validation is still rare. Methods: RNA-Seq-based profiles from NBL patients were acquired and then analyzed. The RNA-Seq prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jian-Guo, Liang, Bo, Jin, Su-Han, Liao, Hui-Ling, Du, Guo-Bo, Cheng, Long, Ma, Hu, Gaipl, Udo S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904333/ https://www.ncbi.nlm.nih.gov/pubmed/31867276 http://dx.doi.org/10.3389/fonc.2019.01361

Ejemplares similares

Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors
por: Zhou, Jian-Guo, et al.
Publicado: (2020)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Bioinformatics Analysis Using ATAC-seq and RNA-seq for the Identification of 15 Gene Signatures Associated With the Prediction of Prognosis in Hepatocellular Carcinoma
por: Yang, Hui, et al.
Publicado: (2021)

Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma
por: Liu, Yunxun, et al.
Publicado: (2023)

Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets
por: Zhong, Xiaodan, et al.
Publicado: (2021)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Serum Protein N-Glycosylation Signatures of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2021)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer
por: Liang, Yichao, et al.
Publicado: (2021)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer
por: Cao, Xueyan, et al.
Publicado: (2022)

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Du, Yi-Heng
Publicado: (2023)

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation
por: Christopoulos, Petros, et al.
Publicado: (2023)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection
por: Luo, Xiao-jie, et al.
Publicado: (2021)

Development and validation of a 21-gene prognostic signature in neuroblastoma
por: Gupta, Mehul, et al.
Publicado: (2023)

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
por: Wang, Jing, et al.
Publicado: (2022)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer
por: Zhang, Ruyue, et al.
Publicado: (2021)

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
por: Du, YiHeng, et al.
Publicado: (2021)

Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data
por: Chai, Ruoyang, et al.
Publicado: (2023)

Development and Validation of a Four Adenosine-to-Inosine RNA Editing Site-Relevant Prognostic Signature for Assessing Survival in Breast Cancer Patients
por: Wan, Jian, et al.
Publicado: (2022)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma
por: Chen, Xin, et al.
Publicado: (2021)

The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins
por: Ming, Ruijie, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis
por: Meng, Xinyao, et al.
Publicado: (2020)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
por: Yao, Jiannan, et al.
Publicado: (2021)

Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma
por: Wang, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqk97759n28l8b56bo05n0hdhs